Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elicio Therapeutics, Inc.ELTX · Entity 299 | Director | August 31, 2026 | September 02, 2026 |
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elicio Therapeutics, Inc.
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.70 · Expires 2036-08-31 | Direct | 21,750 |
Reported balance
After 2026-08-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 21,750 · Balance 21,750 F1: The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders.
ROCKWELL MEDICAL, INC.
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,892 |
Reported balance
After 2026-07-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 9,633 · Balance 23,892 F1: Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting. F2: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
F2: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 20:03 UTC | Elicio Therapeutics, Inc. ELTX · Entity 299 | GrantStock Option (Right to Buy) · Derivative | 21,750 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001441889-26-000002 · wk-form4_1788379430.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,750 Underlying: Common Stock · 21,750 shares Expires 2036-08-31 F1 · derivative.exercise_date: The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 13:26 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 9,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-047126 · wk-form4_1783344377.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,892 F1 · kind: Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting. F2 · balance_after: Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split. Read SEC document |
| May 20, 2025 Filed May 21, 2025 23:07 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-051713 · tm2515860-5_4seq1.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,597 F1 · kind: Restricted stock units vest on May 20, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 19, 2025 Filed May 20, 2025 20:07 UTC | Elicio Therapeutics, Inc. ELTX · Entity 299 | GrantStock Option (Right to Buy) · Derivative | 7,900 | $0.00 Strike: $5.84 | $0.00 |
DisclosureSEC source: 0001601485-25-000089 · wk-form4_1747771647.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,900 Underlying: Common Stock · 7,900 shares Expires 2035-05-19 F1 · shares: The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 12:32 UTC | Elicio Therapeutics, Inc. ELTX · Entity 299 | GrantStock Option (Right to Buy) · Derivative | 4,100 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0001601485-24-000089 · wk-form4_1732537934.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2034-11-21 F1 · shares: The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| May 21, 2024 Filed May 23, 2024 23:02 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 36,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-064810 · tm2415466-1_4seq1.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,597 F1 · kind: Restricted stock units vest on May 21, 2025, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Effective on May 13, 2022, the Issuer effected a 1-for-11 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:05 UTC | Elicio Therapeutics, Inc. ELTX · Entity 299 | GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060239 · form4.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:18 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 24,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064638 · tm2316982-3_4seq1.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,203 F1 · kind: Restricted stock units vest on May 23, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 21:26 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | GrantCommon Stock · Derivative | 15,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001601485-22-000052 · wf-form4_165515558808558.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:30 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-069681 · tm2218111-1_4seq1.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,488 F1 · kind: Restricted stock units vest on June 7, 2023, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 20, 2022 Filed May 23, 2022 23:48 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | PurchaseCommon Stock | 2,037 | $1.18 | $2,403.66 |
DisclosureSEC source: 0001628280-22-015238 · wf-form4_165334970201347.xml · nonDerivative · entry 2 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,383 Read SEC document |
| May 19, 2022 Filed May 23, 2022 23:48 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | PurchaseCommon Stock | 7,346 | $1.16 | $8,521.36 |
DisclosureSEC source: 0001628280-22-015238 · wf-form4_165334970201347.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,346 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:24 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 72,857 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0001628280-21-012667 · wf-form4_162439703839034.xml · derivative · entry 2 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,857 Underlying: Common Stock · 72,857 shares Expires 2031-06-17 F3 · derivative.exercise_date: Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:24 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-012667 · wf-form4_162439703839034.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,488 F1 · kind: Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer. F2 · balance_after: Includes 1,488 shares of common stock underlying unvested restricted stock units that vest on December 11, 2021, subject to the Reporting Person's continued service to the issuer. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:08 UTC | Elicio Therapeutics, Inc. ANG · Entity 299 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0001567619-21-005970 · doc1.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-07 F1 · derivative.exercise_date: To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 21:30 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 1,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-017529 · wf-form4_160806780280961.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,488 F1 · kind: Restricted stock units vest on December 11, 2021, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:17 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 34,639 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001628280-20-009344 · wf-form4_159199304249282.xml · derivative · entry 2 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,639 Underlying: Common Stock · 34,639 shares Expires 2030-06-11 F2 · derivative.exercise_date: Stock options vest on June 11, 2021, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:17 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-009344 · wf-form4_159199304249282.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 F1 · kind: Restricted stock units vest on June 11, 2021, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.